As free tests are now available, one COVID-19 variant continues to be the most prevalent in the United States.

Bristol Myers Squibb wins approval for the first novel schizophrenia drug in decades; Pfizer pulls Oxbryta from the market; ...

We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...

The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...

Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...

Depending on how long it lasts, the dockworkers strike that hit all 14 ports on the U.S. East Coast and along the Gulf Oct. 1 could literally unload a world of hurt to patients and the ...

UW Health's Dr. Bill Hartman discusses a study that warned of "widespread" iron deficiency, the relationship between ...